ChromaTan Inc.

Next Generation Platform for Gene Therapy and mRNA Manufacturing

  • Stage $3M in TTM Revenue
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded January 2012
  • Employees 16
  • Incorporation Type C-corp
  • Website chromatan.com

Company Summary

ChromaTan, a Blue Knight Company, has commercialized the first-ever, single-use, column-free and steady-state continuous chromatography platform called BioRMB that revolutionizes gene therapy and mRNA manufacturing. The company has several pilot units sold to major pharma companies

Studies with leading gene therapy companies have shown up to 20-fold improvements in productivity, using only 10% of the expensive resins used in columns.

Team

  • Oleg Shinkazh, founder and CEO of ChromaTan and the inventor of Continuous Countercurrent Tangential Chromatography (CCTC) now marketed as BioRMB. Oleg is a chemical and biotechnology engineer with 22 years of experience in the biotechnology industry, specializing in downstream processing and purification of biologics. Oleg has been with ChromaTan since October 2009, leading technical and business development of the company.

  • Thiago Millen, PhD
    Associate Director of Process Development

    Thiago is an experienced bioprocess scientist with a broad background in mAbs, viral vectors downstream processing and analytics. Thiago has 13+ years of working experience at fast-paced biotech start-ups as well as large biopharmaceutical companies, in the US and in Brazil, with cross-functional research and development teams. Thiago joined ChromaTan in 2023 and is leading the Process Development team at the company

  • Associate Director, Operations

    Human Resources Management, Project Management, Bookkeeping, Inventory

  • Vice President of Sales and Business Development

    Scott Zobbi is a sales and business development leader with over 30 years of experience. He has a diverse background, from commercial manufacturing and training to product management and business development. Most recently he was Director of Business Development and Strategy at Teknova. Previously, Mr. Zobbi was the head of the POROS custom resin business while at ThermoFisher, fostering the adoption of custom process chromatography solutions

  • David Fogel
    Part Time CFO

    David Fogel (CPA) is Managing Director of Swifton CFOs LLC, an outsourced CFO firm that provides emerging businesses with cost-effective and strategic financial leadership. David’s expertise lies in constructing a reliable financial framework to attract funding. David is Adjunct Instructor of Entrepreneurial Finance at Northeastern University.

Previous Investors

  • Ben Franklin of Central PA $500,000
    Unconfirmed
    Life Science Greenhouse of Central PA $600,000
    Unconfirmed
    Series A - Lehigh Valley Angels $215,000
    Unconfirmed
  • Series A - Ben Franklin of Southeastern PA $250,000
    Unconfirmed
    Series A and Notes - $350,000 Sorensen Family Office
    Unconfirmed
    Frank Li - $1,000,000
    Unconfirmed
  • Zoic Capital - $600,000
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free